208 related articles for article (PubMed ID: 21854270)
1. NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.
Tross S; Campbell AN; Calsyn DA; Metsch LR; Sorensen JL; Shoptaw S; Haynes L; Woody GE; Malow RM; Brown LS; Feaster DJ; Booth RE; Mandler RN; Masson C; Holmes BW; Colfax G; Brooks AJ; Hien DA; Schackman BR; Korthuis PT; Miele GM;
Am J Drug Alcohol Abuse; 2011 Sep; 37(5):283-93. PubMed ID: 21854270
[TBL] [Abstract][Full Text] [Related]
2. Gender research in the National Institute on Drug Abuse National Treatment Clinical Trials Network: a summary of findings.
Greenfield SF; Rosa C; Putnins SI; Green CA; Brooks AJ; Calsyn DA; Cohen LR; Erickson S; Gordon SM; Haynes L; Killeen T; Miele G; Tross S; Winhusen T
Am J Drug Alcohol Abuse; 2011 Sep; 37(5):301-12. PubMed ID: 21854272
[TBL] [Abstract][Full Text] [Related]
3. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network.
Campbell AN; Nunes EV; Miele GM; Matthews A; Polsky D; Ghitza UE; Turrigiano E; Bailey GL; VanVeldhuisen P; Chapdelaine R; Froias A; Stitzer ML; Carroll KM; Winhusen T; Clingerman S; Perez L; McClure E; Goldman B; Crowell AR
Contemp Clin Trials; 2012 Mar; 33(2):386-95. PubMed ID: 22085803
[TBL] [Abstract][Full Text] [Related]
4. The relationship between Clinical Trial Network protocol involvement and quality of substance use disorder treatment.
Abraham AJ; Knudsen HK; Roman PM
J Subst Abuse Treat; 2014 Feb; 46(2):232-7. PubMed ID: 24080073
[TBL] [Abstract][Full Text] [Related]
5. How practice and science are balanced and blended in the NIDA Clinical Trials Network: the bidirectional process in the development of the STAGE-12 protocol as an example.
Donovan DM; Daley DC; Brigham GS; Hodgkins CC; Perl HI; Floyd AS
Am J Drug Alcohol Abuse; 2011 Sep; 37(5):408-16. PubMed ID: 21854284
[TBL] [Abstract][Full Text] [Related]
6. The first decade of the National Drug Abuse Treatment Clinical Trials Network: bridging the gap between research and practice to improve drug abuse treatment.
Tai B; Straus MM; Liu D; Sparenborg S; Jackson R; McCarty D
J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S4-13. PubMed ID: 20307794
[TBL] [Abstract][Full Text] [Related]
7. Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network.
Martino S; Brigham GS; Higgins C; Gallon S; Freese TE; Albright LM; Hulsey EG; Krom L; Storti SA; Perl H; Nugent CD; Pintello D; Condon TP
J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S31-43. PubMed ID: 20307793
[TBL] [Abstract][Full Text] [Related]
8. Quality assurance of research protocols conducted in the community: the National Institute on Drug Abuse Clinical Trials Network experience.
Rosa C; Campbell A; Kleppinger C; Sampson R; Tyson C; Mamay-Gentilin S
Clin Trials; 2009 Apr; 6(2):151-61. PubMed ID: 19342468
[TBL] [Abstract][Full Text] [Related]
9. The design and analysis of multisite effectiveness trials: a decade of progress in the National Drug Abuse Clinical Trials Network.
Nunes EV
Am J Drug Alcohol Abuse; 2011 Sep; 37(5):269-72. PubMed ID: 21854267
[No Abstract] [Full Text] [Related]
10. Women's drug use and HIV risk: findings from NIDA's Cooperative Agreement for Community-Based Outreach/Intervention Research Program.
Coyle SL
Women Health; 1998; 27(1-2):1-18. PubMed ID: 9640631
[No Abstract] [Full Text] [Related]
11. Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?
Nunes EV; Ball S; Booth R; Brigham G; Calsyn DA; Carroll K; Feaster DJ; Hien D; Hubbard RL; Ling W; Petry NM; Rotrosen J; Selzer J; Stitzer M; Tross S; Wakim P; Winhusen T; Woody G
J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S97-112. PubMed ID: 20307801
[TBL] [Abstract][Full Text] [Related]
12. Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection.
Potter JS; Donovan DM; Weiss RD; Gardin J; Lindblad R; Wakim P; Dodd D
Am J Drug Alcohol Abuse; 2011 Sep; 37(5):400-7. PubMed ID: 21854283
[TBL] [Abstract][Full Text] [Related]
13. Ten take home lessons from the first 10 years of the CTN and 10 recommendations for the future.
Carroll KM; Ball SA; Jackson R; Martino S; Petry NM; Stitzer ML; Wells EA; Weiss RD
Am J Drug Alcohol Abuse; 2011 Sep; 37(5):275-82. PubMed ID: 21854269
[TBL] [Abstract][Full Text] [Related]
14. Study results from the Clinical Trials Network's first 10 years: where do they lead?
Wells EA; Saxon AJ; Calsyn DA; Jackson TR; Donovan DM
J Subst Abuse Treat; 2010 Jun; 38 Suppl 1(Suppl 1):S14-30. PubMed ID: 20307792
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal study of organizational formation, innovation adoption, and dissemination activities within the National Drug Abuse Treatment Clinical Trials Network.
Roman PM; Abraham AJ; Rothrauff TC; Knudsen HK
J Subst Abuse Treat; 2010 Jun; 38 Suppl 1():S44-52. PubMed ID: 20307795
[TBL] [Abstract][Full Text] [Related]
16. A systematic scoping review of research on Black participants in the National Drug Abuse Treatment Clinical Trials Network.
Montgomery L; Burlew AK; Haeny AM; Jones CA
Psychol Addict Behav; 2020 Feb; 34(1):117-127. PubMed ID: 31246072
[TBL] [Abstract][Full Text] [Related]
17. Theoretical models used to guide NIDA's cooperative agreement research and intervention efforts. National Institute on Drug Abuse.
Stevens SJ; Kotranski L; Williams M; Bowen AE; McCoy HV
J Psychoactive Drugs; 1998; 30(3):231-8. PubMed ID: 9798788
[TBL] [Abstract][Full Text] [Related]
18. The application of digital health to the assessment and treatment of substance use disorders: The past, current, and future role of the National Drug Abuse Treatment Clinical Trials Network.
Marsch LA; Campbell A; Campbell C; Chen CH; Ertin E; Ghitza U; Lambert-Harris C; Hassanpour S; Holtyn AF; Hser YI; Jacobs P; Klausner JD; Lemley S; Kotz D; Meier A; McLeman B; McNeely J; Mishra V; Mooney L; Nunes E; Stafylis C; Stanger C; Saunders E; Subramaniam G; Young S
J Subst Abuse Treat; 2020 Mar; 112S():4-11. PubMed ID: 32220409
[TBL] [Abstract][Full Text] [Related]
19. Identifying and responding to trial implementation challenges during multisite clinical trials.
Greer TL; Walker R; Rethorst CD; Northrup TF; Warden D; Horigian VE; Silverstein M; Shores-Wilson K; Stotts AL; Trivedi MH
J Subst Abuse Treat; 2020 Mar; 112S():63-72. PubMed ID: 32220413
[TBL] [Abstract][Full Text] [Related]
20. Increasing ethnic minority participation in substance abuse clinical trials: lessons learned in the National Institute on Drug Abuse's Clinical Trials Network.
Burlew K; Larios S; Suarez-Morales L; Holmes B; Venner K; Chavez R
Cultur Divers Ethnic Minor Psychol; 2011 Oct; 17(4):345-56. PubMed ID: 21988575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
